A detailed history of Commonwealth Equity Services, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 95,377 shares of AVXL stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95,377
Previous 94,533 0.89%
Holding current value
$1.07 Million
Previous $399,000 35.84%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$4.11 - $7.04 $3,468 - $5,941
844 Added 0.89%
95,377 $542,000
Q2 2024

Jul 31, 2024

BUY
$3.39 - $5.02 $3,264 - $4,834
963 Added 1.03%
94,533 $399,000
Q1 2024

Apr 29, 2024

BUY
$4.55 - $6.75 $8,099 - $12,015
1,780 Added 1.94%
93,570 $476,000
Q4 2023

Feb 06, 2024

BUY
$5.04 - $9.95 $43,127 - $85,142
8,557 Added 10.28%
91,790 $855,000
Q3 2023

Oct 23, 2023

SELL
$6.55 - $9.37 $31,191 - $44,619
-4,762 Reduced 5.41%
83,233 $545,000
Q2 2023

Aug 10, 2023

BUY
$7.66 - $9.5 $1,723 - $2,137
225 Added 0.26%
87,995 $715,000
Q1 2023

May 11, 2023

SELL
$8.32 - $11.75 $26,998 - $38,128
-3,245 Reduced 3.57%
87,770 $752,000
Q4 2022

Feb 07, 2023

BUY
$7.65 - $14.43 $66,096 - $124,675
8,640 Added 10.49%
91,015 $842,000
Q3 2022

Nov 14, 2022

BUY
$8.9 - $12.86 $2,536 - $3,665
285 Added 0.35%
82,375 $850,000
Q2 2022

Jul 19, 2022

BUY
$7.31 - $12.84 $16,447 - $28,890
2,250 Added 2.82%
82,090 $821,000
Q1 2022

May 04, 2022

BUY
$9.74 - $17.69 $52,751 - $95,809
5,416 Added 7.28%
79,840 $982,000
Q4 2021

Jan 31, 2022

BUY
$16.88 - $23.31 $541,999 - $748,460
32,109 Added 75.88%
74,424 $1.29 Million
Q3 2021

Oct 29, 2021

BUY
$16.82 - $25.75 $9,183 - $14,059
546 Added 1.31%
42,315 $759,000
Q2 2021

Aug 11, 2021

BUY
$10.16 - $28.86 $44,094 - $125,252
4,340 Added 11.6%
41,769 $954,000
Q1 2021

May 04, 2021

SELL
$5.17 - $16.13 $34,230 - $106,796
-6,621 Reduced 15.03%
37,429 $559,000
Q4 2020

Feb 11, 2021

BUY
$4.01 - $7.58 $47,398 - $89,595
11,820 Added 36.67%
44,050 $237,000
Q3 2020

Nov 05, 2020

BUY
$3.8 - $5.0 $1,721 - $2,265
453 Added 1.43%
32,230 $146,000
Q2 2020

Aug 12, 2020

SELL
$2.62 - $5.2 $786 - $1,560
-300 Reduced 0.94%
31,777 $156,000
Q1 2020

May 11, 2020

BUY
$2.38 - $5.81 $4,998 - $12,201
2,100 Added 7.01%
32,077 $101,000
Q4 2019

Feb 05, 2020

BUY
$2.31 - $3.14 $4,139 - $5,626
1,792 Added 6.36%
29,977 $77,000
Q3 2019

Oct 30, 2019

BUY
$2.22 - $3.9 $13,668 - $24,012
6,157 Added 27.95%
28,185 $89,000
Q2 2019

Jul 19, 2019

BUY
$2.75 - $3.7 $4,166 - $5,605
1,515 Added 7.39%
22,028 $74,000
Q1 2019

May 13, 2019

SELL
$1.68 - $3.42 $336 - $684
-200 Reduced 0.97%
20,513 $62,000
Q4 2018

Feb 11, 2019

BUY
$1.25 - $2.75 $7,366 - $16,205
5,893 Added 39.76%
20,713 $32,000
Q3 2018

Nov 06, 2018

BUY
$2.23 - $3.82 $4,460 - $7,640
2,000 Added 15.6%
14,820 $40,000
Q2 2018

Jul 31, 2018

BUY
$2.08 - $4.26 $1,352 - $2,769
650 Added 5.34%
12,820 $34,000
Q1 2018

May 14, 2018

BUY
$2.32 - $3.44 $3,932 - $5,830
1,695 Added 16.18%
12,170 $33,000
Q4 2017

Feb 12, 2018

BUY
$3.12 - $4.94 $32,682 - $51,746
10,475
10,475 $34,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $871M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.